<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">338336</id>
  <title nil="true"/>
  <common-name>2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[(e)-3-(furan-2-yl)prop-2-enylidene]amino]acetamide</common-name>
  <description>2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[(e)-3-(furan-2-yl)prop-2-enylidene]amino]acetamide is a chemical compound with the formula C24H20ClN5O2S. It has an average molecular weight of 478.00 g/mol.</description>
  <cas>307975-51-5</cas>
  <pubchem-id>1833164</pubchem-id>
  <chemical-formula>C24H20ClN5O2S</chemical-formula>
  <weight>478</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T21:25:46Z</created-at>
  <updated-at type="dateTime">2026-08-30T21:25:46Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=CC=C(C=C1)N2C(=NN=C2SCC(=O)NN=CC=CC3=CC=CO3)C4=CC=C(C=C4)Cl</moldb-smiles>
  <moldb-formula>C24H20ClN5O2S</moldb-formula>
  <moldb-inchi>InChI=1S/C24H20ClN5O2S/c1-17-6-12-20(13-7-17)30-23(18-8-10-19(25)11-9-18)28-29-24(30)33-16-22(31)27-26-14-2-4-21-5-3-15-32-21/h2-15H,16H2,1H3,(H,27,31)/b4-2+,26-14+</moldb-inchi>
  <moldb-inchikey>BHMKBRLGVXJTRO-FHSXHZEZSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">477.1026238</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.1</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM334229</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[(e)-3-(furan-2-yl)prop-2-enylidene]amino]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Triazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0288763</sync-id>
  <structure-inchikey>BHMKBRLGVXJTRO-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000200000808000000800000000000000000000000080005000000000000000000002000004008000002080004000000080000000002000200000000000000000400000000000000000000020800000000200000004008010100000001000010080001000000000000000800000000100000000000000000000000000000040020000800000000000200080880000010000000000400000000000000000000000000000000000080000000000000000400000000000102c00400000000000004000000000000000000000000010000000002000000200000000002000000140000000001048000000000482000000010000000040000001000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAhAAAAJAAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:39:08Z</structure-indexed-at>
</compound>
